Zacks Investment Research upgraded shares of CYNOSURE INC-A (CYNO) from UNDERPERFORM to NEUTRAL on July 08, 2014, with a target price of $21.70.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions and temporarily reduce the appearance of cellulite. Cynosure's products incorporate a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag and diode lasers, as well as intense pulsed light.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on CYNOSURE INC-A (CYNO),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment